Clinical Report: Gentamicin-Infused Collagen Implants Reduce SSI in GI Surgery

Overview

Gentamicin-containing collagen implants (GCI) have demonstrated efficacy in reducing surgical site infections (SSI) in gastrointestinal (GI) surgery. Clinical studies show that GCI use leads to lower infection rates, improved wound healing, and shorter hospital stays, particularly in high-risk GI procedures.

Background

Surgical site infections are common complications after GI surgery, associated with increased morbidity and healthcare costs. Traditional prevention relies on systemic antibiotic prophylaxis, but prolonged use may promote antibiotic resistance. Resorbable gentamicin-containing collagen implants offer localized high antibiotic concentrations with minimal systemic exposure, enhancing wound healing and reducing infection risk. These implants combine the antimicrobial effects of gentamicin with collagen's beneficial properties for tissue repair.

Data Highlights

Key Findings

• GCI application significantly reduces SSI rates compared to systemic antibiotics alone in GI surgery.
• Local gentamicin delivery achieves high bactericidal concentrations at the wound site with low systemic levels, minimizing toxicity.
• Collagen in GCI promotes faster coagulation, reduces seroma and hematoma formation, and stimulates fibroblast proliferation aiding wound healing.
• GCI use is associated with shorter wound healing times and reduced length of hospital stay.
• Immune reactions to collagen implants are rare, and implants are fully resorbable, avoiding reoperation.
• GCI may reduce the need for prolonged systemic antibiotic use, potentially lowering antibiotic resistance risk.

Clinical Implications

Incorporating gentamicin-infused collagen implants in GI surgical procedures, especially those at high risk for SSI, can enhance infection prevention while reducing systemic antibiotic exposure. This approach supports improved wound healing and may decrease hospital stay duration, offering both patient and healthcare system benefits.

Conclusion

Gentamicin-containing collagen implants represent a promising adjunct to systemic antibiotic prophylaxis in gastrointestinal surgery, effectively lowering SSI rates and promoting better postoperative outcomes. Their use should be considered in high-risk GI procedures to optimize infection control and recovery.

References

1. Rutten et al. -- Randomised study on GCI in colorectal surgery
2. Systematic Review -- Antibiotic prophylaxis and SSI rates